首页> 美国卫生研究院文献>Springer Open Choice >Health-Related Quality of Life During Routine Treatment with the SQ-Standardised Grass Allergy Immunotherapy Tablet: A Non-Interventional Observational Study
【2h】

Health-Related Quality of Life During Routine Treatment with the SQ-Standardised Grass Allergy Immunotherapy Tablet: A Non-Interventional Observational Study

机译:SQ标准化草过敏免疫治疗片常规治疗期间与健康相关的生活质量:一项非干预性观察研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background and ObjectiveAllergy immunotherapy (AIT) with the SQ® grass sublingual immunotherapy (SLIT)-tablet has been shown to be efficacious, well-tolerated and to improve disease-specific health-related quality of life (HRQoL) in controlled clinical trials. The aim of our study was to investigate HRQoL in patients with allergic rhinoconjunctivitis routinely treated with the SLIT-tablet and taking symptomatic medication as needed compared with patients treated only with symptomatic medication.
机译:背景和目的已证明,使用SQ ®草舌下免疫疗法(SLIT)-平板电脑进行的过敏免疫疗法(AIT)是有效的,耐受性良好的并且可以改善与疾病相关的健康相关生活质量(HRQoL )进行对照临床试验。本研究的目的是调查常规用SLIT片剂治疗并根据需要服用对症药物的变应性鼻结膜炎患者与仅对症药物治疗的患者相比,HRQoL。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号